Difference between revisions of "Fibrinogen A alpha-chain associated amyloidosis"

Jump to: navigation, search
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{SK}} ==Overview== ==Historical Perspective== ==Classification== ==Pathophysiology== ==Causes== ==Epidemiology and Demographics==...")
 
(Historical Perspective)
Line 4: Line 4:
 
{{CMG}}; {{AE}}
 
{{CMG}}; {{AE}}
  
{{SK}}  
+
{{SK}}Fibrinogen amyloidosis
  
 
==Overview==
 
==Overview==
  
 
==Historical Perspective==
 
==Historical Perspective==
 
+
Fibrinogen amyloidosis was first discovered by Dr Merill Benson et al, an American physician, in 1993.
  
 
==Classification==
 
==Classification==

Revision as of 19:36, 4 November 2019

WikiDoc Resources for Fibrinogen A alpha-chain associated amyloidosis

Articles

Most recent articles on Fibrinogen A alpha-chain associated amyloidosis

Most cited articles on Fibrinogen A alpha-chain associated amyloidosis

Review articles on Fibrinogen A alpha-chain associated amyloidosis

Articles on Fibrinogen A alpha-chain associated amyloidosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fibrinogen A alpha-chain associated amyloidosis

Images of Fibrinogen A alpha-chain associated amyloidosis

Photos of Fibrinogen A alpha-chain associated amyloidosis

Podcasts & MP3s on Fibrinogen A alpha-chain associated amyloidosis

Videos on Fibrinogen A alpha-chain associated amyloidosis

Evidence Based Medicine

Cochrane Collaboration on Fibrinogen A alpha-chain associated amyloidosis

Bandolier on Fibrinogen A alpha-chain associated amyloidosis

TRIP on Fibrinogen A alpha-chain associated amyloidosis

Clinical Trials

Ongoing Trials on Fibrinogen A alpha-chain associated amyloidosis at Clinical Trials.gov

Trial results on Fibrinogen A alpha-chain associated amyloidosis

Clinical Trials on Fibrinogen A alpha-chain associated amyloidosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fibrinogen A alpha-chain associated amyloidosis

NICE Guidance on Fibrinogen A alpha-chain associated amyloidosis

NHS PRODIGY Guidance

FDA on Fibrinogen A alpha-chain associated amyloidosis

CDC on Fibrinogen A alpha-chain associated amyloidosis

Books

Books on Fibrinogen A alpha-chain associated amyloidosis

News

Fibrinogen A alpha-chain associated amyloidosis in the news

Be alerted to news on Fibrinogen A alpha-chain associated amyloidosis

News trends on Fibrinogen A alpha-chain associated amyloidosis

Commentary

Blogs on Fibrinogen A alpha-chain associated amyloidosis

Definitions

Definitions of Fibrinogen A alpha-chain associated amyloidosis

Patient Resources / Community

Patient resources on Fibrinogen A alpha-chain associated amyloidosis

Discussion groups on Fibrinogen A alpha-chain associated amyloidosis

Patient Handouts on Fibrinogen A alpha-chain associated amyloidosis

Directions to Hospitals Treating Fibrinogen A alpha-chain associated amyloidosis

Risk calculators and risk factors for Fibrinogen A alpha-chain associated amyloidosis

Healthcare Provider Resources

Symptoms of Fibrinogen A alpha-chain associated amyloidosis

Causes & Risk Factors for Fibrinogen A alpha-chain associated amyloidosis

Diagnostic studies for Fibrinogen A alpha-chain associated amyloidosis

Treatment of Fibrinogen A alpha-chain associated amyloidosis

Continuing Medical Education (CME)

CME Programs on Fibrinogen A alpha-chain associated amyloidosis

International

Fibrinogen A alpha-chain associated amyloidosis en Espanol

Fibrinogen A alpha-chain associated amyloidosis en Francais

Business

Fibrinogen A alpha-chain associated amyloidosis in the Marketplace

Patents on Fibrinogen A alpha-chain associated amyloidosis

Experimental / Informatics

List of terms related to Fibrinogen A alpha-chain associated amyloidosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Synonyms and Keywords: Fibrinogen amyloidosis

Overview

Historical Perspective

Fibrinogen amyloidosis was first discovered by Dr Merill Benson et al, an American physician, in 1993.

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References



Linked-in.jpg